These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 34677400)

  • 1. Defining Acute Coronary Syndrome through Metabolomics.
    Surendran A; Atefi N; Zhang H; Aliani M; Ravandi A
    Metabolites; 2021 Oct; 11(10):. PubMed ID: 34677400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota and metabolomics profiles in patients with chronic stable angina and acute coronary syndrome.
    Ahmad AF; Caparrós-Martin JA; Gray N; Lodge S; Wist J; Lee S; O'Gara F; Dwivedi G; Ward NC
    Physiol Genomics; 2024 Jan; 56(1):48-64. PubMed ID: 37811721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Untargeted Metabolomics Analysis of the Serum Metabolic Signature of Childhood Obesity.
    Szczerbinski L; Wojciechowska G; Olichwier A; Taylor MA; Puchta U; Konopka P; Paszko A; Citko A; Goscik J; Fiehn O; Fan S; Wasilewska A; Taranta-Janusz K; Kretowski A
    Nutrients; 2022 Jan; 14(1):. PubMed ID: 35011090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the Metabolomics of Acute Coronary Syndrome.
    Zhang F; Li B; Su H; Guo Z; Zhu H; Wang A; Jiang K; Cao Y
    Rev Cardiovasc Med; 2023 Jul; 24(7):204. PubMed ID: 39077017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Mass Spectrometry-Based Blood Metabolomics Profiling for Non-Cancer Diseases: A Comprehensive Review.
    Demicheva E; Dordiuk V; Polanco Espino F; Ushenin K; Aboushanab S; Shevyrin V; Buhler A; Mukhlynina E; Solovyova O; Danilova I; Kovaleva E
    Metabolites; 2024 Jan; 14(1):. PubMed ID: 38248857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated metabolomics and metallomics analyses in acute coronary syndrome patients.
    Yin X; de Carvalho LP; Chan MY; Li SFY
    Metallomics; 2017 Jun; 9(6):734-743. PubMed ID: 28518204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical guide to metabolomic profiling as a discovery tool for human heart disease.
    Heather LC; Wang X; West JA; Griffin JL
    J Mol Cell Cardiol; 2013 Feb; 55():2-11. PubMed ID: 23231771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing sensitivity and specificity of the Manchester Triage System in the evaluation of acute coronary syndrome in adult patients in emergency care: a systematic review protocol.
    Nishi FA; de Motta Maia FO; de Lopes Monteiro da Cruz DA
    JBI Database System Rev Implement Rep; 2015 Nov; 13(11):64-73. PubMed ID: 26657465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease.
    Talmor-Barkan Y; Bar N; Shaul AA; Shahaf N; Godneva A; Bussi Y; Lotan-Pompan M; Weinberger A; Shechter A; Chezar-Azerrad C; Arow Z; Hammer Y; Chechi K; Forslund SK; Fromentin S; Dumas ME; Ehrlich SD; Pedersen O; Kornowski R; Segal E
    Nat Med; 2022 Feb; 28(2):295-302. PubMed ID: 35177859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of lipidomics and metabolomics for in-depth understanding of cellular mechanism and disease progression.
    Wang R; Li B; Lam SM; Shui G
    J Genet Genomics; 2020 Feb; 47(2):69-83. PubMed ID: 32178981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Metabolomic Characterization of Coronary Artery Diseases.
    Fan Y; Li Y; Chen Y; Zhao YJ; Liu LW; Li J; Wang SL; Alolga RN; Yin Y; Wang XM; Zhao DS; Shen JH; Meng FQ; Zhou X; Xu H; He GP; Lai MD; Li P; Zhu W; Qi LW
    J Am Coll Cardiol; 2016 Sep; 68(12):1281-93. PubMed ID: 27634119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic and lipidomic assessment of the metabolic syndrome in Dutch middle-aged individuals reveals novel biological signatures separating health and disease.
    Surowiec I; Noordam R; Bennett K; Beekman M; Slagboom PE; Lundstedt T; van Heemst D
    Metabolomics; 2019 Feb; 15(2):23. PubMed ID: 30830468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of endogenic metabolites by rosuvastatin in hyperlipidemia patients: An integration of metabolomics and lipidomics.
    Lee H; Choi JM; Cho JY; Kim TE; Lee HJ; Jung BH
    Chem Phys Lipids; 2018 Aug; 214():69-83. PubMed ID: 29852124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics study reveals that statin therapy is associated with restoration of gut microbiota homeostasis and improvement in outcomes in patients with acute coronary syndrome.
    Hu X; Li H; Zhao X; Zhou R; Liu H; Sun Y; Fan Y; Shi Y; Qiao S; Liu S; Liu H; Zhang S
    Theranostics; 2021; 11(12):5778-5793. PubMed ID: 33897881
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolomics analysis identifies a lipidomic profile in treatment-naïve juvenile dermatomyositis patients vs healthy control subjects.
    Dvergsten JA; Reed AM; Landerman L; Pisetsky DS; Ilkayeva O; Huffman KM
    Rheumatology (Oxford); 2022 Apr; 61(4):1699-1708. PubMed ID: 34185053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Metabolomics Reveals Distinct Profiles during Ischemia and Reperfusion in a Porcine Model of Myocardial Ischemia-Reperfusion.
    Goetzman E; Gong Z; Rajasundaram D; Muzumdar I; Goodchild T; Lefer D; Muzumdar R
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic phenotyping and cardiovascular disease: an overview of evidence from epidemiological settings.
    Iliou A; Mikros E; Karaman I; Elliott F; Griffin JL; Tzoulaki I; Elliott P
    Heart; 2021 Jul; 107(14):1123-1129. PubMed ID: 33608305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UPLC-MS based plasma metabolomics and lipidomics reveal alterations associated with IgG4-related disease.
    Gong Y; Zhang P; Liu Z; Li J; Lu H; Wang Y; Qiu B; Wang M; Fei Y; Chen H; Peng L; Li J; Zhou J; Shi Q; Zhang X; Shen M; Zeng X; Zhang F; Zhang W
    Rheumatology (Oxford); 2021 Jul; 60(7):3252-3261. PubMed ID: 33341881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.
    Cheng S; Shah SH; Corwin EJ; Fiehn O; Fitzgerald RL; Gerszten RE; Illig T; Rhee EP; Srinivas PR; Wang TJ; Jain M;
    Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28360086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease.
    Meikle PJ; Formosa MF; Mellett NA; Jayawardana KS; Giles C; Bertovic DA; Jennings GL; Childs W; Reddy M; Carey AL; Baradi A; Nanayakkara S; Wilson AM; Duffy SJ; Kingwell BA
    J Am Heart Assoc; 2019 Jun; 8(11):e011792. PubMed ID: 31131674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.